BVF Inc/il, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 32 shares at $3.80 ($122) on 2020-09-22, disclosed to the SEC on 2020-09-24.
Open-market purchase of $122 FPRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PNT | SELL | 2023-12-20 | $427.3M | — | Filing → |
| CGEM | BUY | 2022-05-16 | $20.1M | — | Filing → |
| KYMR | BUY | 2022-05-09 | $8.3M | — | Filing → |